William Demant Holdings ROE 2012-2019 | WILYY

Current and historical return on equity (ROE) values for William Demant Holdings (WILYY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. William Demant Holdings ROE for the three months ending December 31, 2019 was 0.00%.
William Demant Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.296B $2.241B
Demant A/S is engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company's business area consists of Hearing Devices, Hearing Implants, Diagnostic Instruments and Personal Communication. Demant A/S, formerly known as William Demant Holding A/S, is based in Smorum, Denmark.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.547B 28.36
Medtronic (MDT) Ireland $122.957B 19.97
Stryker (SYK) United States $67.597B 21.94
Boston Scientific (BSX) United States $48.473B 22.79
Baxter (BAX) United States $43.366B 26.47
Lonza Group Ag (LZAGY) Switzerland $41.278B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.090B 0.00
Terumo (TRUMY) Japan $28.292B 36.17
ResMed (RMD) United States $27.700B 43.72
Zimmer Biomet Holdings (ZBH) United States $24.149B 15.19
Sunny Optical Technology (SNPTF) China $19.634B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.266B 0.00
Bio-Rad Laboratories (BIO) United States $13.885B 63.20
Insulet (PODD) United States $13.004B 1288.31
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.449B 74.25
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.525B 13.46
Hill-Rom Holdings (HRC) United States $7.400B 20.86
GN STORE NORD (GNNDY) Denmark $6.972B 35.54
Canopy Growth (CGC) Canada $5.789B 0.00
Haemonetics (HAE) United States $4.583B 27.53
Neogen (NEOG) United States $4.086B 69.21
GW Pharmaceuticals (GWPH) United Kingdom $4.024B 0.00
ICU Medical (ICUI) United States $3.902B 28.46
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.865B 0.00
Agios Pharmaceuticals (AGIO) United States $3.743B 0.00
Envista Holdings (NVST) United States $3.353B 0.00
NuVasive (NUVA) United States $2.707B 21.74
TG Therapeutics (TGTX) United States $2.492B 0.00
National Vision Holdings (EYE) United States $2.340B 40.49
AtriCure (ATRC) United States $1.733B 0.00
MacroGenics (MGNX) United States $1.492B 0.00
Aurora Cannabis (ACB) Canada $1.407B 0.00
NanoString Technologies (NSTG) United States $1.391B 0.00
Aphria (APHA) Canada $1.239B 0.00
Cerus (CERS) United States $1.168B 0.00
Cardiovascular Systems (CSII) United States $1.071B 0.00
Phibro Animal Health (PAHC) United States $1.046B 20.85
Meridian Bioscience (VIVO) United States $1.011B 38.06
PetIQ (PETQ) United States $0.961B 27.75
InMode (INMD) Israel $0.913B 19.28
Vapotherm (VAPO) United States $0.900B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.898B 149.54
Zynex (ZYXI) United States $0.864B 86.80
OraSure Technologies (OSUR) United States $0.805B 162.13
Omeros (OMER) United States $0.796B 0.00
Quanterix (QTRX) United States $0.768B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.641B 45.94
VAREX IMAGING (VREX) United States $0.581B 14.44
Surmodics (SRDX) United States $0.573B 69.05
Lantheus Holdings (LNTH) United States $0.571B 11.48
LeMaitre Vascular (LMAT) United States $0.537B 30.56
Owens & Minor (OMI) United States $0.476B 12.60
BioLife Solutions (BLFS) United States $0.457B 159.86
Viemed Healthcare (VMD) United States $0.397B 35.21
Cytosorbents (CTSO) United States $0.365B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.318B 0.00
HEXO (HEXO) $0.312B 0.00
Utah Medical Products (UTMD) United States $0.312B 22.62
Organigram Holdings (OGI) Canada $0.279B 0.00
Female Health (VERU) United States $0.217B 0.00
InfuSystems Holdings (INFU) United States $0.216B 119.67
Chimerix (CMRX) United States $0.189B 0.00
Surface Oncology (SURF) United States $0.184B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Exagen (XGN) United States $0.143B 0.00
Fonar (FONR) United States $0.137B 12.18
Evolus (EOLS) United States $0.130B 0.00
Rockwell Medical (RMTI) United States $0.130B 0.00
United Health Products (UEEC) United States $0.126B 0.00
Liberty Health Sciences (LHSIF) Canada $0.112B 0.00
Wound Management Technologies (SMTI) United States $0.110B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.104B 0.00
MTech Acquisition (KERN) United States $0.101B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.078B 0.00
Chembio Diagnostics (CEMI) United States $0.077B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.068B 15.80
Capricor Therapeutics (CAPR) United States $0.063B 0.00
Brainsway (BWAY) Israel $0.062B 0.00
Trinity Biotech (TRIB) Ireland $0.061B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00